NeuroPace (NPCE) Cash from Financing Activities (2020 - 2026)

NeuroPace's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$166000.0 for Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 100.79% year-over-year to -$166000.0 in Q1 2026; TTM through Mar 2026 was -$1.7 million, a 106.6% decrease from a year earlier, with the FY2025 full-year figure at $19.6 million, up 352.97% from the prior year.
• Cash from Financing Activities declined to -$166000.0 in Q1 2026 per NPCE's latest filing, from $635000.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $21.1 million in Q1 2025 and bottomed at -$1.9 million in Q2 2025.
• The 5-year median for Cash from Financing Activities is $72000.0 (2024), against an average of $1.9 million.
• Across the five-year window, Cash from Financing Activities tumbled 25600.0% in 2023 and soared 29216.67% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$138000.0 in 2022, then surged by 6052.17% to $8.2 million in 2023, then slumped by 89.68% to $848000.0 in 2024, then slipped by 25.12% to $635000.0 in 2025, then tumbled by 126.14% to -$166000.0 in 2026.
• Per Business Quant, the three latest NPCE Cash from Financing Activities figures stand at -$166000.0 (Q1 2026), $635000.0 (Q4 2025), and -$235000.0 (Q3 2025).